Parkinson's Disease study: LIFUS
Official title LIFUS For Neurological Disorders
ClinicalTrials.gov ID: NCT07417280
What this study is testing
- What it's testing
- This study aims to see how low-intensity focused ultrasound affects brain activity in patients with movement disorders to understand if it could be a useful treatment.
- Who it's for
- People with movement disorders such as Parkinson's disease, essential tremor, dystonia, or epilepsy.
- What's involved
- Participants will receive low-intensity focused ultrasound, a non-invasive sound wave treatment, to the brain while researchers measure changes in brain activity.
- Time commitment
- The source text does not specify the total duration or number of visits required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85. Healthy volunteers may be eligible.
You may be able to join if
- 18-85 years of age
- Patients diagnosed with neurological disorders, (such as epilepsy, brain tumour, movement disorders) or psychiatric disorders (such as substance...
- Patients undergoing medical or surgical treatment (such as DBS) for neurological disorders
You likely can't join if
- History of stroke
- Comorbid dementia
- Scored below 22 on the Montreal Cognitive Assessment (MoCA)
- Has an implanted cardiac pacemaker or implantable cardioverter-defibrillator (ICD)
- Presence of metal implanted in body that is contraindicated in TMS/MRI
- Pregnancy
See the full eligibility criteria
- 18-85 years of age
- Patients diagnosed with neurological disorders, (such as epilepsy, brain tumour, movement disorders) or psychiatric disorders (such as substance abuse disorder)
- Patients undergoing medical or surgical treatment (such as DBS) for neurological disorders
- History of stroke
- Comorbid dementia
- Scored below 22 on the Montreal Cognitive Assessment (MoCA)
- Has an implanted cardiac pacemaker or implantable cardioverter-defibrillator (ICD)
- Presence of metal implanted in body that is contraindicated in TMS/MRI
- Pregnancy
- Major depression/psychiatric disorder that in the opinion of the Investigator will affect patient's understanding of study procedures and willingness to abide by all procedures during the course of the study
- Receiving a psychotropic medication or taking recreational substances that in the opinion of the investigator will significantly affect safety of the protocol
- Major systemic illness or infection
The study team makes the final eligibility decision.
Where it is enrolling
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.